Suppr超能文献

常染色体显性多囊肾病的进展机制

Mechanisms of progression in autosomal dominant polycystic kidney disease.

作者信息

Grantham J J

机构信息

Department of Medicine, Kansas University Medical Center, Kansas City, USA.

出版信息

Kidney Int Suppl. 1997 Dec;63:S93-7.

PMID:9407432
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) progresses to end-stage renal insufficiency before the age of 73 in approximately 48% of affected individuals. Why the disease, characterized by innumerable cysts arising in proximal and distal tubules, eliminates functioning non-cystic parenchyma in some patients and spares other is a mystery. The cysts initiate in early childhood in fewer than 1% of renal tubules as a consequence of the focal expression of mutated DNA. Tubule cells proliferate, causing segmental dilation, in association with the abnormal deposition of extracellular matrix proteins. Most of the cysts separate from the parent tubules and fill with fluid by cAMP-mediated chloride secretion. Risk factors associated with accelerated loss of renal function include: genotype (PKD Type 1 progresses more rapidly than PKD Type 2); gender (males progress more rapidly than females); race (black patients progress more rapidly than whites); hypertension; proteinuria. The relation between kidney size and progression to renal failure is debated. Progressive PKD is associated with the cellular expression of proto-oncogenes (fos, myc, ras, erb), growth factors (EGF, HGF, acid and basic FGF), chemokines (MCP-1. osteopontin), metalloproteinases, and apoptotic markers, and the interstitial accumulation of Types I and IV collagen, laminin, fibronectin, macrophages and fibroblasts, the magnitudes of which increase with age. Cyst activating factor (CAF), a neutral lipid identified in cyst fluid that stimulates fluid secretion and proliferation of renal epithelial cells and monocyte chemotaxis, has recently been identified as a potential progression factor. In those patients destined to develop renal failure there is loss of non-cystic parenchyma in association with mass replacement by fluid-filled cysts in a network of interstitial fibrosis. The decline in renal function is probably the consequence of processes leading to interstitial fibrosis, as in other nephropathies, rather than due to simple mechanical displacement of parenchyma by cysts.

摘要

常染色体显性多囊肾病(ADPKD)在约48%的患者中会在73岁之前发展为终末期肾功能不全。这种以近端和远端肾小管中出现无数囊肿为特征的疾病,为何在一些患者中会破坏有功能的非囊肿性实质,而在另一些患者中却能幸免,仍是个谜。由于突变DNA的局部表达,囊肿在儿童早期始于不到1%的肾小管。肾小管细胞增殖,导致节段性扩张,并伴有细胞外基质蛋白的异常沉积。大多数囊肿与母肾小管分离,并通过环磷酸腺苷(cAMP)介导的氯化物分泌充满液体。与肾功能加速丧失相关的危险因素包括:基因型(PKD1型比PKD2型进展更快);性别(男性比女性进展更快);种族(黑人患者比白人进展更快);高血压;蛋白尿。肾脏大小与肾衰竭进展之间的关系存在争议。进行性PKD与原癌基因(fos、myc、ras、erb)、生长因子(表皮生长因子、肝细胞生长因子、酸性和碱性成纤维细胞生长因子)、趋化因子(单核细胞趋化蛋白-1、骨桥蛋白)、金属蛋白酶和凋亡标志物的细胞表达有关,以及I型和IV型胶原、层粘连蛋白、纤连蛋白、巨噬细胞和成纤维细胞的间质积聚,其程度随年龄增加。囊肿激活因子(CAF)是一种在囊肿液中发现的中性脂质,可刺激肾上皮细胞的液体分泌和增殖以及单核细胞趋化,最近被确定为一种潜在的进展因子。在那些注定要发展为肾衰竭的患者中,非囊肿性实质丧失,同时在间质纤维化网络中被充满液体的囊肿大量替代。肾功能下降可能是导致间质纤维化的过程的结果,就像其他肾病一样,而不是由于囊肿对实质的简单机械性挤压。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验